Botulinum toxin in spinal cord injury patients with neurogenic detrusor overactivity
Young Sam Cho, Khae Hawn Kim
J Exerc Rehabil. 2016;12(6):624-631.   Published online 2016 Dec 27     DOI:
Citations to this article as recorded by Crossref logo
Kurzfassung der S2k-Leitlinie medikamentöse Therapie der neurogenen Dysfunktion des unteren Harntraktes (NLUTD)
J. Kutzenberger, A. Angermund, B. Domurath, S. Möhr, J. Pretzer, I. Soljanik, R. Kirschner-Hermanns
Die Urologie.2023; 62(1): 41.     CrossRef
A Primary Care Provider’s Guide to Management of Neurogenic Lower Urinary Tract Dysfunction and Urinary Tract Infection After Spinal Cord Injury
James Milligan, Lance L. Goetz, Michael J. Kennelly
Topics in Spinal Cord Injury Rehabilitation.2020; 26(2): 108.     CrossRef
A Korean Postmarketing Study Assessing the Effectiveness of OnabotulinumtoxinA for the Treatment of Neurogenic Detrusor Overactivity or Idiopathic Overactive Bladder Using a Validated Patient-Reported Outcome Measure
Kwang Jin Ko, Brenda Jenkins, Anand Patel, Kyu-Sung Lee
International Neurourology Journal.2019; 23(1): 30.     CrossRef
Persistent urine leakage around a suprapubic catheter: the experience of a person with chronic tetraplegia
Subramanian Vaidyanathan, Jerry Ward, Bakul M. Soni, Peter Hughes, Tun Oo
Spinal Cord Series and Cases.2018;[Epub]     CrossRef
Broaden and Build Up Knowledge Based on Investigative and Clinical Research
Khae Hawn Kim
International Neurourology Journal.2017; 21(1): 3.     CrossRef